US Bancorp’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59 Hold
43
﹤0.01% 4138
2026
Q1
$39 Hold
43
﹤0.01% 4141
2025
Q4
$49 Hold
43
﹤0.01% 4010
2025
Q3
$61 Hold
43
﹤0.01% 3970
2025
Q2
$60 Hold
43
﹤0.01% 4123
2025
Q1
$50 Hold
43
﹤0.01% 4154
2024
Q4
$61 Hold
43
﹤0.01% 4119
2024
Q3
$65 Hold
43
﹤0.01% 4042
2024
Q2
$74 Hold
43
﹤0.01% 3932
2024
Q1
$50 Hold
43
﹤0.01% 3934
2023
Q4
$44 Hold
43
﹤0.01% 3930
2023
Q3
$58 Hold
43
﹤0.01% 3948
2023
Q2
$49 Hold
43
﹤0.01% 3953
2023
Q1
$50 Hold
43
﹤0.01% 4056
2022
Q4
$48 Hold
43
﹤0.01% 4104
2022
Q3
$0 Sell
43
-7
-14% -$15 ﹤0.01% 4171
2022
Q2
$0 Buy
50
+7
+16% +$13 ﹤0.01% 4164
2022
Q1
$0 Hold
43
﹤0.01% 4157
2021
Q4
$0 Hold
43
﹤0.01% 4189
2021
Q3
$0 Hold
43
﹤0.01% 4152
2021
Q2
$0 Hold
43
﹤0.01% 4051
2021
Q1
$0 Hold
43
﹤0.01% 3939
2020
Q4
$0 Hold
43
﹤0.01% 3852
2020
Q3
$0 Hold
43
﹤0.01% 3804
2020
Q2
$0 Buy
43
+38
+760% +$264 ﹤0.01% 3823
2020
Q1
$0 Hold
5
﹤0.01% 3758
2019
Q4
$0 Hold
5
﹤0.01% 3700
2019
Q3
$0 Buy
5
+1
+25% +$4 ﹤0.01% 3645
2019
Q2
$0 Hold
4
﹤0.01% 3648
2019
Q1
$0 Hold
4
﹤0.01% 3619
2018
Q4
$0 Hold
4
﹤0.01% 3661
2018
Q3
$0 Hold
4
﹤0.01% 3680
2018
Q2
$0 Hold
4
﹤0.01% 3660
2018
Q1
$0 Hold
4
﹤0.01% 3666
2017
Q4
$0 Hold
4
﹤0.01% 3655
2017
Q3
$0 Hold
4
﹤0.01% 3617
2017
Q2
$0 Hold
4
﹤0.01% 3583
2017
Q1
$0 Hold
4
﹤0.01% 3604
2016
Q4
$0 Hold
4
﹤0.01% 3603
2016
Q3
$0 Hold
4
﹤0.01% 3587
2016
Q2
$0 Hold
4
﹤0.01% 3606
2016
Q1
$0 Hold
4
﹤0.01% 3613
2015
Q4
$0 Hold
4
﹤0.01% 3672
2015
Q3
$0 Hold
4
﹤0.01% 3647
2015
Q2
$0 Hold
4
﹤0.01% 3612
2015
Q1
$0 Hold
4
﹤0.01% 3604
2014
Q4
$0 Hold
4
﹤0.01% 3593
2014
Q3
$0 Hold
4
﹤0.01% 3550
2014
Q2
$0 Hold
4
﹤0.01% 3529
2014
Q1
$0 Hold
4
﹤0.01% 3523
2013
Q4
$0 Buy
+4
New +$412 ﹤0.01% 3450

Other funds holding NNVC

US Bancorp's NNVC Position: Q2 2026 in Review

US Bancorp held its NanoViricides (NNVC) position steady in Q2 2026 at 43 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #4138.

US Bancorp first reported a position in NNVC in Q4 2013 and has held it in 51 quarters since. The position peaked at $74 in Q2 2024. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • US Bancorp held 43 shares of NanoViricides worth $59 as of Q2 2026.
  • US Bancorp left its NanoViricides share count unchanged in Q2 2026.
  • NanoViricides made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4138 holding.
  • US Bancorp first reported a position in NanoViricides in Q4 2013 and has held it in 51 quarters since.
  • US Bancorp's NanoViricides position peaked at $74 in Q2 2024.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.